AI Science Tracker
EN

Raman spectra and neural learning distinguish three melanoma cell lines

University of Florence · 18 Dec 2020 · medicine

Discovery

Raman spectra and neural learning distinguish three melanoma cell lines

Source check: Source checked. Not independent scientific confirmation.

Finding: A neural classifier distinguished Raman spectra from three melanoma cell lines carrying different BRAF or NRAS variants, including a rare BRAF variant. The study collected 50 spectra per line and reported 96.7% accuracy with five-fold spectral cross-validation. This is an in-vitro cell-line measurement, with feature-selection and spectrum-level evaluation caveats; it does not demonstrate independent patient diagnosis or establish that genotype caused the spectral differences.

Technology: Artificial neural network; principal-component features

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

AI contribution
A feed-forward neural network learns nonlinear boundaries from principal-component Raman features to discriminate the measured cell lines.
Test and result
New Raman measurements from three melanoma cell lines, with neural and linear-discriminant spectral classification.
Limitation / still unknown
Independent cultures, patient-level diagnosis and causal assignment of spectral differences to genotype remain unestablished.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://doi.org/10.1002/jbio.202000365

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 21 Nov 2026. Review scope: Primary relevant Methods/results/limitations and exact front/canonical identity; current primary PubMed linked correction/retraction metadata checked..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.